Pharmaceutical quality and compliance platform (pqcp)
Ended Awarded Last action
- Contract number
- HHSF22316001
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,495,019
Award facts
- Opportunity
-
- TFTPMC000874B Solicitation number
- Contract value 100% obligated
- $2,495,019.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R699 Support- Administrative: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- North Bethesda, MD 20852, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,021 | |
| Other Administrative Action | $0 | |
| Original award | $2,496,041 |
About this award
This is a federal contract award by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a leading management and technology services firm, for a Pharmaceutical Quality and Compliance Platform (PQCP). The $2,495,019.10 contract is a BPA Call under the Mission Oriented Business Integrated Services (MOBIS) GSA Schedule, with a period of performance through December 2019. The contract does not have a set-aside designation. Booz Allen Hamilton Inc. is the prime contractor, and the parent company is Booz Allen Hamilton Holding Corporation. The contract involves providing the FDA with services related to pharmaceutical quality and compliance, leveraging Booz Allen Hamilton's expertise in areas such as consulting, analytics, and cybersecurity. This award demonstrates the company's ability to support critical government initiatives across various federal agencies, including the FDA's efforts to modernize technologies and enhance operational capabilities in the pharmaceutical sector.
Quick answers
Who was awarded contract HHSF22316001?
HHSF22316001 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on February 8, 2016.
How much is contract HHSF22316001 worth?
The government has obligated $2,495,019 on HHSF22316001.
Is contract HHSF22316001 an order under another contract?
Yes. HHSF22316001 is a BPA call under GS23F9755H-HHSF223201510005B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).
Was contract HHSF22316001 competed?
The extent of competition for HHSF22316001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award